Drug Type Small molecule drug |
Synonyms Jamein |
Target |
Mechanism ORAI1 inhibitors(Calcium release-activated calcium channel protein 1 inhibitors), mAChRs antagonists(Muscarinic acetylcholine receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date KR (16 Jan 2024), |
Regulation- |
Molecular FormulaC17H20N4O6 |
InChIKeyAUNGANRZJHBGPY-SCRDCRAPSA-N |
CAS Registry83-88-5 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Motion Sickness | KR | 16 Jan 2024 |